Literature DB >> 32086501

Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.

Matt D Johansen1, Jean-Louis Herrmann2,3, Laurent Kremer4,5.   

Abstract

Infections caused by non-tuberculous mycobacteria (NTM) are increasing globally and are notoriously difficult to treat due to intrinsic resistance of these bacteria to many common antibiotics. NTM are diverse and ubiquitous in the environment, with only a few species causing serious and often opportunistic infections in humans, including Mycobacterium abscessus. This rapidly growing mycobacterium is one of the most commonly identified NTM species responsible for severe respiratory, skin and mucosal infections in humans. It is often regarded as one of the most antibiotic-resistant mycobacteria, leaving us with few therapeutic options. In this Review, we cover the proposed infection process of M. abscessus, its virulence factors and host interactions and highlight the commonalities and differences of M. abscessus with other NTM species. Finally, we discuss drug resistance mechanisms and future therapeutic options. Taken together, this knowledge is essential to further our understanding of this overlooked and neglected global threat.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32086501     DOI: 10.1038/s41579-020-0331-1

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  195 in total

1.  Anonymous mycobacteria in pulmonary disease.

Authors:  E H RUNYON
Journal:  Med Clin North Am       Date:  1959-01       Impact factor: 5.456

Review 2.  Rapidly Growing Mycobacteria.

Authors:  Barbara A Brown-Elliott; Julie V Philley
Journal:  Microbiol Spectr       Date:  2017-01

3.  Massive gene decay in the leprosy bacillus.

Authors:  S T Cole; K Eiglmeier; J Parkhill; K D James; N R Thomson; P R Wheeler; N Honoré; T Garnier; C Churcher; D Harris; K Mungall; D Basham; D Brown; T Chillingworth; R Connor; R M Davies; K Devlin; S Duthoy; T Feltwell; A Fraser; N Hamlin; S Holroyd; T Hornsby; K Jagels; C Lacroix; J Maclean; S Moule; L Murphy; K Oliver; M A Quail; M A Rajandream; K M Rutherford; S Rutter; K Seeger; S Simon; M Simmonds; J Skelton; R Squares; S Squares; K Stevens; K Taylor; S Whitehead; J R Woodward; B G Barrell
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

4.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Authors:  Kenneth N Olivier; David J Weber; Richard J Wallace; Ali R Faiz; Ji-Hyun Lee; Yansheng Zhang; Barbara A Brown-Elliot; Allison Handler; Rebecca W Wilson; Michael S Schechter; Lloyd J Edwards; Subha Chakraborti; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 5.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  The new phylogeny of the genus Mycobacterium: The old and the news.

Authors:  Enrico Tortoli; Tarcisio Fedrizzi; Conor J Meehan; Alberto Trovato; Antonella Grottola; Elisabetta Giacobazzi; Giulia Fregni Serpini; Sara Tagliazucchi; Anna Fabio; Clotilde Bettua; Roberto Bertorelli; Francesca Frascaro; Veronica De Sanctis; Monica Pecorari; Olivier Jousson; Nicola Segata; Daniela M Cirillo
Journal:  Infect Genet Evol       Date:  2017-10-11       Impact factor: 3.342

Review 7.  Nontuberculous mycobacteria: Insights on taxonomy and evolution.

Authors:  Christine Y Turenne
Journal:  Infect Genet Evol       Date:  2019-01-14       Impact factor: 3.342

Review 8.  Mycobacterial diseases other than tuberculosis.

Authors:  E Wolinsky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 9.  Environmental sources of nontuberculous mycobacteria.

Authors:  Joseph O Falkinham
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

10.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

View more
  128 in total

1.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

2.  Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.

Authors:  Jin Lee; Nicole Ammerman; Anusha Agarwal; Maram Naji; Si-Yang Li; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Stepwise pathogenic evolution of Mycobacterium abscessus.

Authors:  Josephine M Bryant; Karen P Brown; Sophie Burbaud; Isobel Everall; Juan M Belardinelli; Daniela Rodriguez-Rincon; Dorothy M Grogono; Chelsea M Peterson; Deepshikha Verma; Ieuan E Evans; Christopher Ruis; Aaron Weimann; Divya Arora; Sony Malhotra; Bridget Bannerman; Charlotte Passemar; Kerra Templeton; Gordon MacGregor; Kasim Jiwa; Andrew J Fisher; Tom L Blundell; Diane J Ordway; Mary Jackson; Julian Parkhill; R Andres Floto
Journal:  Science       Date:  2021-04-30       Impact factor: 47.728

4.  Rifabutin Is Inactivated by Mycobacterium abscessus Arr.

Authors:  Daniel Schäfle; Petra Selchow; Barbara Borer; Michael Meuli; Anna Rominski; Bettina Schulthess; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

5.  Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.

Authors:  Maria Carla Martini; Tianbi Zhang; John T Williams; Robert B Abramovitch; Pamela J Weathers; Scarlet S Shell
Journal:  J Ethnopharmacol       Date:  2020-07-27       Impact factor: 4.360

6.  Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.

Authors:  Matt D Johansen; Wassim Daher; Françoise Roquet-Banères; Clément Raynaud; Matthéo Alcaraz; Florian P Maurer; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

7.  Mycobacterium avium: an Emerging Pathogen for Dog Breeds with Hereditary Immunodeficiencies.

Authors:  Giovanni Ghielmetti; Urs Giger
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-18

8.  Disseminated cutaneous Mycobacterium abscessus infection in a patient with chronic renal failure [corrected].

Authors:  Shuaihantian Luo; Hongsheng Wang; Guiying Zhang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

9.  A Molecular-Beacon-Based Multiplex Real-Time PCR Assay To Distinguish Mycobacterium abscessus Subspecies and Determine Macrolide Susceptibility.

Authors:  Salvatore A E Marras; Liang Chen; Elena Shashkina; Rebecca M Davidson; Michael Strong; Charles L Daley; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

10.  Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?

Authors:  Gajapathiraju Chamarthi; Dhruv Modi; Kenneth Andreoni; Ashutosh M Shukla
Journal:  CEN Case Rep       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.